The current IT market for genomics and molecular laboratories only offers isolated solutions to support certain business capabilities. There is no comprehensive solution that supports end-to-end lab processes, for example, which creates a barrier to entry into the genomics space.
When Genosity, a biotechnology company, wanted to build a solution to help labs more easily navigate the complicated landscape of molecular informatics, the company turned to its longstanding partner EPAM.
Alongside Genosity, EPAM developed and deployed an Integrated Genomics Toolkit (IGT). Today, this leading, comprehensive research solution reduces the obstacles blocking many labs and health systems from leveraging next-generation sequencing (NGS) data. Read the full case study to learn more.